A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient

NCT03557099 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Aplastic Anemia

Interventions

DRUG: Hetrombopag Olamine

Sponsor

Jiangsu HengRui Medicine Co., Ltd.